Hall Render

MARCH 20, 2024

The improved information requirements apply to the following payers, including: Medicare Advantage plans; Medicaid and Children’s Health Insurance Program (“CHIP”) managed care plans; State Medicaid and CHIP fee-for-service payers; and Qualified Health Plans only in the Federally Facilitated Exchanges.

Medicare 40

Medicare Medicare Health Insurance Medicaid 40

Healthcare Law Blog

JANUARY 26, 2024

The payers impacted by the Final Rule include Medicare Advantage (“MA”) organizations, state Medicaid and Children’s Health Insurance Program (“CHIP”) agencies, Medicaid and CHIP managed care plans, and plans on the Affordable Care Act exchanges (collectively, “Impacted Payers”).

US Department of Health and Human Services 52

US Department of Health and Human Services Medicare Medicare Medicaid 52

Health Care Law Brief

FEBRUARY 2, 2024

The Waiver Amendment was approved on January 9, 2024, by the Centers for Medicare & Medicaid Services (“CMS”) under Section 1115(a) of the Social Security Act and will expire on March 31, 2027. Level I HRSN services are paid for outside of the Waiver Amendment via fee for service or managed care.

Medicaid 52

Medicaid Medicaid Medicare Medicare 52

Healthcare Law Blog

AUGUST 25, 2022

Fifteen more Part D drugs are set to be published in 2027, followed by 15 Part D and Part B drugs, collectively, in 2028. Program Compliance. Drug manufacturers may also be assessed an excise tax between 65%-95% depending upon the number of days that the drug manufacturer is out of compliance. Negotiation-Eligible Drugs.

Medicare 52

Medicare Medicare Medicaid Medicaid 52